MT3 and esophageal squamous cell carcinoma: As shown in Figure 1D, 5‐year overall survival (OS) rate of ESCC patients with MT3‐MMP down‐regulation (score ≤4, median survival = 50.69 months) was significantly lower than those with score >4 (median survival = 30.77 months; P = 0.029).